157 related articles for article (PubMed ID: 14692709)
21. Softgel capsule technology as an enhancer device for the absorption of natural principles in humans. A bioavailability cross-over randomised study on silybin.
Savio D; Harrasser PC; Basso G
Arzneimittelforschung; 1998 Nov; 48(11):1104-6. PubMed ID: 9850434
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic interaction between oltipraz and silymarin in rats.
Kang MK; Bae SK; Kim JW; Lee MG
J Pharm Pharm Sci; 2009; 12(1):1-16. PubMed ID: 19470289
[TBL] [Abstract][Full Text] [Related]
23. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
24. Relative bioavailability of diclofenac potassium from softgel capsule versus powder for oral solution and immediate-release tablet formulation.
Bende G; Biswal S; Bhad P; Chen Y; Salunke A; Winter S; Wagner R; Sunkara G
Clin Pharmacol Drug Dev; 2016 Jan; 5(1):76-82. PubMed ID: 27119581
[TBL] [Abstract][Full Text] [Related]
25. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
Bramer SL; Forbes WP
Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
[TBL] [Abstract][Full Text] [Related]
26. Comparative bioavailability of two fluconazole capsule formulations in healthy volunteers.
Ribeiro W; Zappi EA; Moraes ME; Bezerra FA; Lerner FE; de Nucci G
Arzneimittelforschung; 2000 Nov; 50(11):1028-32. PubMed ID: 11148859
[TBL] [Abstract][Full Text] [Related]
27. Study on dose-linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay.
Weyhenmeyer R; Mascher H; Birkmayer J
Int J Clin Pharmacol Ther Toxicol; 1992 Apr; 30(4):134-8. PubMed ID: 1572758
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and bioequivalence study of valacyclovir hydrochloride capsules after single dose administration in healthy Chinese male volunteers.
Lin H; Tian Y; Tian JX; Zhang ZJ; Mao GG
Arzneimittelforschung; 2010; 60(3):162-7. PubMed ID: 20422949
[TBL] [Abstract][Full Text] [Related]
29. Comparative bioavailability cf two amlodipine formulation in healthy volunteers.
Setiawati E; Sukmayadi ; Yunaidi DA; Handayani LR; Harinanto G; Santoso ID; Deniati SH
Arzneimittelforschung; 2007; 57(7):467-71. PubMed ID: 17803060
[TBL] [Abstract][Full Text] [Related]
30. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
Martins ML; Pierossi MA; Moraes LA; Ribeiro W; Abbib Júnior E; Mendes GB; Poli A; De Nucci G; Muscará MN
Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287
[TBL] [Abstract][Full Text] [Related]
31. Relative bioavailability of single doses of prolonged-release tacrolimus administered as a suspension, orally or via a nasogastric tube, compared with intact capsules: a phase 1 study in healthy participants.
Undre N; Dickinson J
BMJ Open; 2017 Apr; 7(4):e012252. PubMed ID: 28377389
[TBL] [Abstract][Full Text] [Related]
32. Development of a HPLC-UV assay for silybin-phosphatidylcholine complex (silybinin capsules) and its pharmacokinetic study in healthy male Chinese volunteers.
Li W; Gao J; Zhao HZ; Liu CX
Eur J Drug Metab Pharmacokinet; 2006; 31(4):265-70. PubMed ID: 17315537
[TBL] [Abstract][Full Text] [Related]
33. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
[TBL] [Abstract][Full Text] [Related]
34. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects.
Barzaghi N; Crema F; Gatti G; Pifferi G; Perucca E
Eur J Drug Metab Pharmacokinet; 1990; 15(4):333-8. PubMed ID: 2088770
[TBL] [Abstract][Full Text] [Related]
36. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
37. Diclofenac potassium 25 mg liquid capsules: earlier and higher exposure to diclofenac. A fasted, single-dose, comparative bioavailability study vs. diclofenac potassium 2 x 12.5 mg tablets.
Armogida M; Gold M
Int J Clin Pharmacol Ther; 2012 Jun; 50(6):445-51. PubMed ID: 22677306
[TBL] [Abstract][Full Text] [Related]
38. Methylphenidate bioavailability from two extended-release formulations.
González MA; Pentikis HS; Anderl N; Benedict MF; DeCory HH; Dirksen SJ; Hatch SJ
Int J Clin Pharmacol Ther; 2002 Apr; 40(4):175-84. PubMed ID: 11996212
[TBL] [Abstract][Full Text] [Related]
39. Comparative bioavailability of two immediate release tablets of enalapril/hydrochlorothiazide in healthy volunteers.
Maya MT; Goncalves NJ; Silva NE; Filipe AE; Morais JA; Caturla MC; Rovira M
Eur J Drug Metab Pharmacokinet; 2002; 27(2):91-9. PubMed ID: 12064377
[TBL] [Abstract][Full Text] [Related]
40. Three-ways crossover bioequivalence study of cephalexin in healthy Malay volunteers.
Liew KB; Peh KK; Loh GO; Tan YT
Drug Dev Ind Pharm; 2014 Sep; 40(9):1156-62. PubMed ID: 23688276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
